Reducing risk of complications associated with tissue ablation
AssigneeUniversity of Rochester
InventorGeorge A. HOLLAND
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Rochester
InventorGeorge A. HOLLAND
Estimating the term…
Methods and systems are described that reduce risks of hematologic, metabolic, and renal complications in a mammal, such as a human, undergoing tissue ablation. One such method includes inserting a probe into a mammal and ablating abnormal tissue in the mammal by emitting a first amount of energy from the probe. In some embodiments, after emitting the first amount of energy, a method can include denaturing proteins released from cells in the abnormal tissue by emitting a second amount of energy from at least one of the first probe or a second probe inserted into the mammal. Furthermore, some embodiments can be implemented such that during or after the emitting the energy from a probe, a composition is administered to the mammal in an effective amount to denature proteins released from cells in the abnormal tissue.
A method for reducing a risk of hematologic and/or metabolic complications in a mammal undergoing tissue ablation, comprising:
A method of reducing a risk of hematologic and metabolic complications in a mammal undergoing tissue ablation, comprising:
Dependencies are inferred from the claim text.